To mark the first academic meeting on disease mongering (the "selling of sickness" in order to promote drug sales), which was held in Newcastle, Australia in April 2006, and to help provoke…

In September 2010, the PLOS Medicine Debate asked whether drug companies are living up to their human rights responsibilities. Sofia Gruskin and Zyde Raadfrom the Harvard School of Public Health say…

Ghostwriting occurs when someone has made substantial contributions to writing a manuscript but this role is unacknowledged. In medicine, ghostwriting is problematical because it often involves…

In the spirit of Open Con and highlighting the state of Open Data, PLOS is proud to release our Open Data Collection. In collaboration with our external advisor, Melissa Haendel, we have selected…

In January 2010 PLOS Medicine launched a four-part series examining the ways in which global health institutions and arrangements are changing and evolving. The series aims to stimulate debate…

Epigenetics is the study of inherited changes in phenotype or gene expression caused by mechanisms other than changes in the underlying DNA sequence. This collection brings together twenty research…

Drug research in malaria often focuses on blood stage parasites because they are responsible for the symptoms of the disease and are easier to manipulate in the laboratory.This collection describes…

This collection of essays, perspectives, and reviews from six PLOS journals provides insights into how genomics can revolutionize our understanding of emerging infectious disease. Produced with…

Dramatic reductions in the cost of sequencing, as well advances in sequencing technologies, have enabled key insights into the genomic alterations and somatic mutations that lead to cancer and…

Cancers figure among the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancer related deaths each year. It is expected that annual cancer…